|
Director: George F. Murphy, M.D.
The purpose of this new core is to provide expertise and resources in all aspects of in situ characterization of intact tissue at both transcriptional and post-transcriptional levels. The Core thus facilitates interactive research that requires the following analyses: interpretation of pathological alterations by conventional and microscopy and transmission electron microscopy; immunohistochemistry; immunofluorescence; TUNEL labeling; in situ hybridization; and laser capture microdissection for RT-PCR, microarray, and proteomic analyses. The Core emphasizes coordinated use of several of these approaches as well as use of double/multiple simultaneous labels to address more precisely define pathogenic tissue alterations. Image analysis technology is also utilized to quantify and expedite the various analyses available through this Core.
|
|
|